title: Bladder-sparing approach in the treatment of invasive bladder cancer.
authors.affiliation: Division of Urology, School of Medicine, University of Florida, Gainesville 32611.
authors.forename: Z
authors.initials: Z
authors.lastname: Wajsman
authors.forename: R
authors.initials: R
authors.lastname: Marino
authors.forename: J
authors.initials: J
authors.lastname: Parsons
authors.forename: D
authors.initials: D
authors.lastname: Oblon
authors.forename: D
authors.initials: D
authors.lastname: McCarley
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D015653:Cystectomy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D011882:Radiotherapy, High-Energy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate